EXTRA: The Opioid Tragedy — How We Got Here

Existing drugs can sometimes be repurposed to treat rare diseases. But making that match can be hard — and the financial incentives are weak. Guest host Steve Levitt tries to solve the puzzle. SOURCES: Chris Snyder, professor of economics at Dartmouth College. David Fajgenbaum, c ...  Show more

When Richard Thaler first published Nudge, the world was just starting to believe in his brand of behavioral economics. In this 2021 episode, we ask: How has nudge theory held up in the face of a global financial meltdown, a pandemic, and other existential crises? SOURCES:Richard ...  Show more

"We should never, ever forget that addiction treatment is a search for meaning in a place other than using drugs."

—Nancy Campbell, historian of drug addiction

(This is the third and final chapter of a three-part se ...

CPSolvers: Anti-Racism in Medicine Series  Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction Show Notes by Alec Calac February 9, 2022 Summary: This episode highlights racialized disparities in addiction treatment. During ...  Show more

For 37 years, Rick Doblin has been pushing the F.D.A. to approve treating post-traumatic stress disorder with MDMA, better known as Ecstasy. He tells Steve why he persisted for so long, why he doesn’t like calling drug use “recreational,” and what he learned from his pet wolf. ...

<span style="font-weight: 400;">The United States is in the midst of an epidemic of addiction and overdose deaths due to opiate painkillers. Its causes are varied, but there's no question that physicians share a large part of the blame. Little discussed is that this is actuall ...